Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD
On Jul. 3, 2024, Regeneron Pharmaceuticals and Sanofi announced that the European Commission (EC) has approved Dupixent® (dupilumab)…
On Jul. 3, 2024, Regeneron Pharmaceuticals and Sanofi announced that the European Commission (EC) has approved Dupixent® (dupilumab)…
On Jul. 2, 2024, scientists at the National Institutes of Health (NIH) have uncovered a brain circuit in…
On Jul. 2, 2024, Emergent BioSolutions announced it had received more than $250 millionin contract modifications from the…
On Jul. 1, 2024, scientists at the U.S. Department of Agriculture (USDA)’s Agricultural Research Service (ARS) and university research partners…
On Jun. 28, 2024, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
On Jun. 27, 2024, the U.S. Food and Drug Administration granted marketing authorization to Cepheid for the Xpert…
On Jun. 27, 2024, the U.S. Centers for Disease Control and Prevention’s (CDC) recommended the updated 2024-2025 COVID-19…
On Jun. 26, 2024, National Institute of Allergy and Infectious Diseases (NIAID) announced that research has led to…
On Jun. 26. 2024, the World Health Organization reported that new data show that nearly one third (31%)…
On Jun. 26, 2024, the U.S. Centers for Disease Control and Prevention (CDC) updated its recommendation for the…
On Jun. 25, 2024, Merck Animal Health announced U.S. Department of Agriculture (USDA) approval of NOBIVAC® NXT Canine…
On Jun. 25, 2024, Evotec announced that its Seattle-based subsidiary, Just – Evotec Biologics, was selected by the…
On Jun. 25, 2024, the Finnish Institute for Health and Welfare (THL) announced that they planned to offer…
On Jun. 25, 2024 the Centers for Disease Control and Prevention (CDC) issued a Health Alert Network (HAN)…
On Jun. 24, 2024, Novo Nordisk announced plans to invest 4.1 billion US dollars to build a second…
On Jun. 20, 2024, the U.S. Food and Drug Administration expanded the approval of Sarepta Therapeutics’ Elevidys (delandistrogene…
On Jun. 19, 2024, the Institute for Health Metrics and Evaluation (IHME) released a comprehensive new report that…
On Jun. 18, 2024, the Houston Zoo announced that Tess, a 40-year-old Asian elephant at the Zoo, had…
On Jun. 17, 2024, Merck announced that the U.S. Food and Drug Administration (FDA) had approved CAPVAXIVE™ (Pneumococcal…
On Jul. 16, 2024, Colorado Parks and Wildlife officials announced the first finding of ‘rustrela virus’ in a…
On Jun. 14, 2024 the Centers for Disease Control and Prevention reported data from this study suggested that…
On Jun. 14, 2024, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) unanimously voted to recommend…
On Jun. 14, 2024, the National Institute of Allergy and Infectious Diseases (NIAID, Reported that the amount of…
On Jun. 13. 2024, University of Minnesota researchers announced they have successfully mapped the complete genome of the…
On Jun. 13, 2024, the Oklahoma BioScience Association (OKBio), a 501(c)(3) corporation was rebranded Life Science Oklahoma. Life…
On Jun. 12, 2024, scientists at Weill Cornell Medicine in New York City reported that just a few…
On Jun. 13, 2024, BioMADE announced an investment in a state-of-the-art bioindustrial manufacturing infrastructure in Minnesota, following support…
On Jun. 11, 2024, the National Academies of Sciences, Engineering, and Medicine released a new report that stated the…
On Jun. 10, 2024, Roche announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use…
On Jun. 7, 2024, the Institute of Evolutionary Biology in Barcelona announced an analysis of genome data from…